Surmodics Announces 2017 Annual Shareholders Meeting
February 09 2017 - 8:00AM
Business Wire
Virtual Meeting on February 14 at 4:00 p.m.
(CT)
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that its virtual Annual Meeting of
Shareholders will be held on Tuesday, February 14, at 4:00
p.m. CT (5:00 p.m. ET).
Gary Maharaj, chief executive officer, and Sue Knight, chair of
the board, will provide a brief update on business and key
strategic initiatives underway at the Company.
To attend the meeting, go to
www.virtualshareholdermeeting.com/SRDX17 five minutes prior to the
start of the meeting to log in. In addition, the Annual Meeting
audio presentation will be archived on the Company’s website
following the meeting.
About Surmodics, Inc.Surmodics is the global leader in
surface modification technologies for intravascular medical devices
and a leading provider of chemical components for in vitro
diagnostic (IVD) tests and microarrays. Following two recent
acquisitions of Creagh Medical and NorMedix, the Company is
executing a key growth strategy for its medical device business by
expanding to offer total intravascular product solutions to its
medical device customers. The combination of proprietary surface
technologies, along with enhanced device design, development and
manufacturing capabilities, enables Surmodics to significantly
increase the value it offers with highly differentiated
intravascular solutions designed and engineered to meet the most
demanding requirements. With this focus on offering total product
solutions, Surmodics’ mission remains to improve the detection and
treatment of disease by using its technology to provide solutions
to difficult medical device and diagnostic challenges. Surmodics is
headquartered in Eden Prairie, Minnesota. For more information
about the company, visit www.surmodics.com. The content of
Surmodics’ website is not part of this press release or part of any
filings that the company makes with the SEC.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170209005197/en/
Surmodics, Inc.Andy LaFrence,
952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Aug 2024 to Sep 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Sep 2023 to Sep 2024